Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 2Head and Neck Neoplasms 2Mucositis 1Head and Neck Cancer Patients Treated With Radiotherapy 1

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Low-Level Light Therapy 4Cisplatin 4Mouthwashes 3Control Groups 3Water 2Standard of Care 2Sodium Chloride 2Sodium Bicarbonate 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Propolis 2Laser Therapy 2Injections 2FGF20 protein, human 2Drug Therapy 2Chlorhexidine 2Benzydamine 2Ascorbic Acid 2whole grape extract 1sargramostim 1samital 1peppermint oil 1oxycodone-acetaminophen 1meclocycline 1golotimod 1dusquetide 1calcium phosphate 1brilacidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Stomatitis × Benzydamine × Clear all
NCT05055726 2022-11-16

BOOM

Aziende Chimiche Riunite Angelini Francesco S.p.A

Phase 4 Completed
100 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT00051441 2011-05-19

Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3 Completed
605 enrolled

Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡